HARPOON THERAPEUTICS, INC.

Profile

Company Names

HARPOON THERAPEUTICS, INC.

Addresses

611 GATEWAY BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA 94080

131 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA 94080

4000 SHORELINE COURT, SUITE 250, SOUTH SAN FRANCISCO, CA 94080

4000 SHORELINE CT #250, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

(650) 443-7400
650-443-7400

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$220,347,668.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-10-25 
$100,162,467.00 
$100,162,467.00 
$0.00 
Equity 
3
2023-03-23 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
2
2018-11-09 
$69,999,993.00 
$69,999,993.00 
$0.00 
Equity 
1
2017-05-24 
$25,185,208.00 
$45,185,208.00 
$20,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PATRICK 
 
BAEUERLE 
DIRECTOR
HARPOON THERAPEUTICS, INC.   |  WEREWOLF THERAPEUTICS, INC.
JOSEPH 
 
BAILES 
DIRECTOR
HARPOON THERAPEUTICS, INC.   |  7 HILLS PHARMA INC.
PABLO 
 
CAGNONI 
DIRECTOR
CRISPR THERAPEUTICS AG   |  HARPOON THERAPEUTICS, INC.
MARK 
 
CHIN 
DIRECTOR
OPTIKIRA, LLC   |  ITERUM THERAPEUTICS LTD   |  HARPOON THERAPEUTICS, INC.   |  AURA BIOSCIENCES, INC.   |  VELOSBIO INC.   |  IMARA INC.   |  ITERUM THERAPEUTICS BERMUDA LTD   |  ITERUM THERAPEUTICS PLC   |  ITERUM THERAPEUTICS US LTD   |  ITERUM THERAPEUTICS US HOLDING LTD   |  ITERUM THERAPEUTICS INTERNATIONAL LTD   |  SORRISO PHARMACEUTICALS, INC.   |  ENSOMA, INC.   |  AVENZOAR PHARMACEUTICALS, INC.
ALAN 
 
COLOWICK 
DIRECTOR
NORA THERAPEUTICS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  VELOSBIO INC.   |  INCARDA THERAPEUTICS, INC.   |  SOLVE THERAPEUTICS, INC.   |  RECODE THERAPEUTICS, INC.   |  ANUMANA, INC.   |  HARPOON THERAPEUTICS, INC.   |  ALUMIS INC.
JONATHAN 
 
DRACHMAN 
DIRECTOR
CALITHERA BIOSCIENCES, INC.   |  HARPOON THERAPEUTICS, INC.   |  ABACUS BIOSCIENCE INC.
JULIE 
 
EASTLAND 
EXECUTIVE OFFICER, DIRECTOR
HARPOON THERAPEUTICS, INC.   |  SEISMIC THERAPEUTIC, INC.
GEORGIA 
L. 
ERBEZ 
EXECUTIVE OFFICER
HARPOON THERAPEUTICS, INC.
LUKE 
 
EVNIN 
DIRECTOR
ENTEROMEDICS INC   |  MPM BIOVENTURES V, L.P.   |  COSTIM PHARMACEUTICALS INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  ONCORUS, INC.   |  BLADE THERAPEUTICS, INC.   |  DIGITX PARTNERS LLC   |  TRIEZA THERAPEUTICS, INC.   |  MAVERICK THERAPEUTICS INC.   |  HARPOON THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  MPM ONCOLOGY INNOVATIONS FUND LP   |  FRONTIER MEDICINES CORP   |  WEREWOLF THERAPEUTICS, INC.   |  UMOJA BIOPHARMA, INC.   |  REDONA THERAPEUTICS, INC.
DAN 
 
HICKLIN 
DIRECTOR
MAVERICK THERAPEUTICS INC.   |  HARPOON THERAPEUTICS, INC.
RON 
 
HUNT 
DIRECTOR
SPINE WAVE, INC   |  KALIDEX PHARMACEUTICALS, INC.   |  ILLUMINOSS MEDICAL INC   |  RELYPSA INC   |  NEW LEAF GROWTH FUND I, L.P.   |  NEURONETICS, INC.   |  HARPOON THERAPEUTICS, INC.   |  QLARIS BIO, INC.   |  RALLYBIO HOLDINGS, LLC   |  CURASEN THERAPEUTICS, INC.
RONALD 
 
HUNT 
DIRECTOR
AMERICAN CHARTERED, LLC   |  STROMEDIX INC   |  HARPOON THERAPEUTICS, INC.
GERALD 
 
MCMAHON 
EXECUTIVE OFFICER, DIRECTOR
TRELLIS BIOSCIENCE INC   |  KOLLTAN PHARMACEUTICALS INC   |  HARPOON THERAPEUTICS, INC.
SCOTT 
 
MYERS 
DIRECTOR
ECODUAL, LLC   |  HARPOON THERAPEUTICS, INC.   |  SELECTA BIOSCIENCES INC   |  CALIFORNIA BANCORP   |  AVELO, INC.
WILLIAM 
E. 
PICHT 
EXECUTIVE OFFICER
HARPOON THERAPEUTICS, INC.
ANDREW 
 
ROBBINS 
DIRECTOR
PINEY POINT ONSHORE FUND LP   |  HARPOON THERAPEUTICS, INC.   |  RL PARENT HOLDINGS LLC
NATALIE 
R. 
SACKS 
EXECUTIVE OFFICER
HARPOON THERAPEUTICS, INC.   |  CARIBOU BIOSCIENCES, INC.
LAUREN 
 
SILVERNAIL 
DIRECTOR
EVOLUS, INC.   |  HARPOON THERAPEUTICS, INC.
LAUREN 
P. 
SILVERNAIL 
DIRECTOR
HARPOON THERAPEUTICS, INC.
JOANNE 
 
VINEY 
DIRECTOR
HARPOON THERAPEUTICS, INC.   |  SEISMIC THERAPEUTIC, INC.
LUKE 
 
WALKER 
EXECUTIVE OFFICER
MONDIAL LIFE FUND LLC   |  HARPOON THERAPEUTICS, INC.   |  WALKER BROTHERS BEVERAGE CO.   |  ASPIRE DIGITAL GOLD, LLC   |  STARLIGHT SOFTWARE SOLUTIONS, LLC
LUKE 
NATHANIEL 
WALKER 
EXECUTIVE OFFICER
HARPOON THERAPEUTICS, INC.
HOLGER 
 
WESCHE 
EXECUTIVE OFFICER
HARPOON THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-10-31
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$5,000,001 - $25,000,000 
Equity 
2023-10-25 
2023-04-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$25,000,001 - $100,000,000 
Equity 
2023-03-23 
2018-11-26
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
2017-06-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
COWEN AND COMPANY, LLC
7616
CANACCORD GENUITY CORP.
NONE
CANACCORD GENUITY LLC
1020
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375